Home>Home Page Articles>
New Emprove® Program: Fast track through the regulatory maze
“As the regulatory landscape continues to evolve, rapid and easy access to risk assessment information is even more critical. The expansion of our Emprove® program helps ensure our customers are using only the highest quality products for their manufacturing processes.”
— Udit Batra, CEO MilliporeSigma
New Emprove® Program:
For drug manufacturers, complying with strict standards and ever-changing regulations is a huge challenge. Creating documentation for pharma and biopharma products can be costly and time-consuming.
Fast track through the regulatory maze
As a leading supplier for the pharmaceutical and biopharmaceutical industry, we understand this. For more than a decade, we have led the industry in providing regulatory documentation and information through our Emprove® portfolio of approximately 400 raw and starting raw materials used in the manufacturing of drug products, even as the number of regulations has increased. Now we’re broadening our scope by expanding our portfolio and providing detailed information on filters and single-use components for bioproduction processes.
The Emprove® program offers instant access to online regulatory and technical information on a wide range of products, such as details on extractables, residual solvents and elemental impurities, thus facilitating global drug manufacturers’ qualification, risk assessment and process optimization efforts.
Specific Customer Benefits Include:
Click here to watch from tablet or mobile device.
- Expediting approval preparation and extending compliance
- Facilitating qualification processes
- Supporting risk assessment, management and mitigation
- Increasing supply chain transparency
- Saving you time and money